NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS

Aim. To evaluate antianginal and antiischemic efficiency of nebivolol in patients with stable angina pectoris.Material and methods. 100 patients with ischemic heart disease showing stable exertional angina pectoris and having no contraindications to beta-blockers were studied. After 5-7 days of cont...

Full description

Saved in:
Bibliographic Details
Main Authors: Y. V. Gavrilov, V. A. Sulimov, V. I. Makolkin
Format: Article
Language:English
Published: Столичная издательская компания 2015-12-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/404
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227979023974400
author Y. V. Gavrilov
V. A. Sulimov
V. I. Makolkin
author_facet Y. V. Gavrilov
V. A. Sulimov
V. I. Makolkin
author_sort Y. V. Gavrilov
collection DOAJ
description Aim. To evaluate antianginal and antiischemic efficiency of nebivolol in patients with stable angina pectoris.Material and methods. 100 patients with ischemic heart disease showing stable exertional angina pectoris and having no contraindications to beta-blockers were studied. After 5-7 days of control period 50 randomly selected patients began to take nebivolol in initial dose of 5mg once daily and 50 patients started to take metoprolol in initial dose of 50 mg twice daily. Duration of treatment was 8 weeks. Efficiency of treatment was assessed according to the results of control treadmill assessment and control daily ECG monitoring.Results. 56-day therapy with nebivolol at a dose of 7,5 mg per day results in increase in duration of treadmill test before angina or ST depression (p<0.05). Antianginal and antiischemic effect of nebivolol 7.5 mg once daily is rather similar with that of metoprolol in average daily dose of 175 mg. Nebivolol compared to metoprolol significantly (p<0.05) more effectively reduces the number of silent myocardial ischemia.Conclusion. Nebivolol is an efficient antianginal and antiischemic drug for patients with stable exertional angina pectoris.
format Article
id doaj-art-ecd8dc29930046f780167f4c286952b5
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2015-12-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-ecd8dc29930046f780167f4c286952b52025-08-23T10:00:19ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-0132111510.20996/1819-6446-2007-3-2-11-15404NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORISY. V. Gavrilov0V. A. Sulimov1V. I. Makolkin2Moscow Medical Academy named after I.M. SechenovMoscow Medical Academy named after I.M. SechenovMoscow Medical Academy named after I.M. SechenovAim. To evaluate antianginal and antiischemic efficiency of nebivolol in patients with stable angina pectoris.Material and methods. 100 patients with ischemic heart disease showing stable exertional angina pectoris and having no contraindications to beta-blockers were studied. After 5-7 days of control period 50 randomly selected patients began to take nebivolol in initial dose of 5mg once daily and 50 patients started to take metoprolol in initial dose of 50 mg twice daily. Duration of treatment was 8 weeks. Efficiency of treatment was assessed according to the results of control treadmill assessment and control daily ECG monitoring.Results. 56-day therapy with nebivolol at a dose of 7,5 mg per day results in increase in duration of treadmill test before angina or ST depression (p<0.05). Antianginal and antiischemic effect of nebivolol 7.5 mg once daily is rather similar with that of metoprolol in average daily dose of 175 mg. Nebivolol compared to metoprolol significantly (p<0.05) more effectively reduces the number of silent myocardial ischemia.Conclusion. Nebivolol is an efficient antianginal and antiischemic drug for patients with stable exertional angina pectoris.https://www.rpcardio.online/jour/article/view/404stable exertional angina pectorissilent myocardial ischemianebivololmetoprololantianginal and antiischemic action
spellingShingle Y. V. Gavrilov
V. A. Sulimov
V. I. Makolkin
NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
Рациональная фармакотерапия в кардиологии
stable exertional angina pectoris
silent myocardial ischemia
nebivolol
metoprolol
antianginal and antiischemic action
title NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
title_full NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
title_fullStr NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
title_full_unstemmed NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
title_short NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
title_sort nebivolol in treatment of stable exertional angina pectoris
topic stable exertional angina pectoris
silent myocardial ischemia
nebivolol
metoprolol
antianginal and antiischemic action
url https://www.rpcardio.online/jour/article/view/404
work_keys_str_mv AT yvgavrilov nebivololintreatmentofstableexertionalanginapectoris
AT vasulimov nebivololintreatmentofstableexertionalanginapectoris
AT vimakolkin nebivololintreatmentofstableexertionalanginapectoris